Failure of endotoxin-free superoxide dismutase to reduce some paw edemas and adjuvant arthritis in rats

Inflamm Res. 1999 Feb;48(2):63-6. doi: 10.1007/s000110050405.

Abstract

Objective and design: To elucidate whether superoxide anion plays a major role in inflammation models in rats. Endotoxin-free CuZn superoxide (SOD) was used in the present study, because we had shown previously that even a trace of endotoxin contamination of SOD would carry anti-inflammatory effects.

Material and treatment: Male rats were treated with saline (n=8-10), recombinant human SOD (n=8-10), and dexamethasone or indomethacin (n=8-10).

Methods: Foot volume was determined by mercury displacement.

Results: Two administrations of SOD (5 and 50 mg/kg), 2 h and just before irritant injection, had no effect on rat paw edema induced by phorbol, zymosan or carrageenan. Two administrations of dexamethasone (1 mg/kg) or indomethacin (3 mg/kg), 2 h and just before irritation, inhibited paw edema significantly (p<0.05). Administration of SOD (10 mg/kg) once daily for 3 weeks from the day of mycobacterium injection had no effect on injected paw swelling and non-injected paw swelling 7, 14, 21 days after irritation. Indomethacin (2 mg/kg) once daily for 3 weeks inhibited this arthritis significantly (p < 0.05).

Conclusions: Superoxide anion may not play a major role in the genesis of inflammation in these rat inflammation models, and endotoxin-like contaminants may have contributed to some protective effects of SOD administration in previous studies.

MeSH terms

  • Animals
  • Arthritis, Experimental / drug therapy*
  • Edema / drug therapy*
  • Endotoxins / therapeutic use*
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Recombinant Proteins / therapeutic use
  • Superoxide Dismutase / therapeutic use*

Substances

  • Endotoxins
  • Recombinant Proteins
  • Superoxide Dismutase